Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
IndexS&P 500 P/E- EPS (ttm)-1.62 Insider Own0.40% Shs Outstand208.25M Perf Week-7.24%
Market Cap15.20B Forward P/E13.96 EPS next Y5.23 Insider Trans0.00% Shs Float204.58M Perf Month-10.65%
Income-249.30M PEG- EPS next Q1.09 Inst Own100.00% Short Float4.41% Perf Quarter-13.25%
Sales3.01B P/S5.05 EPS this Y-4.70% Inst Trans12.45% Short Ratio4.13 Perf Half Y-18.47%
Book/sh33.19 P/B2.20 EPS next Y15.48% ROA-4.90% Target Price101.57 Perf Year14.17%
Cash/sh12.15 P/C6.01 EPS next 5Y13.50% ROE-16.70% 52W Range57.14 - 96.58 Perf YTD1.22%
Dividend- P/FCF64.88 EPS past 5Y-33.10% ROI-7.70% 52W High-24.41% Beta1.48
Dividend %- Quick Ratio2.00 Sales past 5Y14.50% Gross Margin46.00% 52W Low27.76% ATR3.22
Employees5062 Current Ratio2.20 Sales Q/Q24.00% Oper. Margin17.70% RSI (14)36.21 Volatility3.80% 4.32%
OptionableYes Debt/Eq0.88 EPS Q/Q-296.00% Profit Margin-21.00% Rel Volume0.72 Prev Close74.46
ShortableYes LT Debt/Eq0.87 EarningsAug 10 BMO Payout- Avg Volume2.18M Price73.00
Recom1.90 SMA20-8.58% SMA50-11.29% SMA200-11.35% Volume1,576,692 Change-1.96%
Sep-01-15Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-17-15Upgrade RBC Capital Mkts Outperform → Top Pick $98 → $107
Jun-15-15Reiterated Stifel Buy $95 → $115
Jun-03-15Initiated Raymond James Mkt Perform
May-29-15Reiterated Guggenheim Buy $100 → $110
May-22-15Reiterated Cantor Fitzgerald Hold $80 → $92
Apr-16-15Reiterated Piper Jaffray Overweight $102 → $110
Apr-13-15Reiterated Deutsche Bank Buy $91 → $96
Mar-03-15Reiterated RBC Capital Mkts Outperform $80 → $98
Feb-02-15Reiterated CRT Capital Fair Value $73 → $80
Jan-30-15Reiterated Deutsche Bank Buy $81 → $91
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-01-15 03:11PM  Endo International: Uncertain Growth Beyond 2017? at Barrons.com
08:52AM  Growth Uncertainty For Endo Continues Through 2017
06:32AM  Endo Health downgraded by Morgan Stanley
Aug-31-15 10:55AM  Drug launch in Japan to trigger $20M payment to Endo at bizjournals.com
08:00AM  Endo Pharmaceuticals Announces XIAFLEX® for Dupuytren's Contracture Formal Pricing in Japan; Commercial Launch Set for September 16, 2015 PR Newswire
08:00AM  Endo Pharmaceuticals Announces XIAFLEX® for Dupuytren's Contracture Formal Pricing in Japan; Commercial Launch Set for September 16, 2015 CNW Group
Aug-29-15 12:34PM  Mid-cap Healthcare Stocks The Smart Money Is Crazy About at Insider Monkey
Aug-26-15 11:32AM  Drug Deal Valuations Soar as Par Gains 300%: Real M&A at Bloomberg
Aug-25-15 11:55AM  Pharmaceutical Stocks Affect the iShares NASDAQ Biotechnology ETF
Aug-20-15 01:04PM  ENDO INTERNATIONAL PLC Financials
Aug-17-15 04:30PM  Endo Gets Favorable Ruling Related to Opana ER in U.S.
10:40AM  Court ruling upholds Endo pain product patents at bizjournals.com
10:39AM  Top Mid-Cap Stocks Smart Money Love: Cheniere Energy Inc. (LNG), Liberty Interactive Corporation (QVCA) & Others at Insider Monkey
Aug-14-15 06:26PM  Endo Wins Order Blocking Generic of Opana ER Until 2023 at Bloomberg
03:30PM  Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property PR Newswire
03:30PM  Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property CNW Group
09:05AM  What Were the Valuations for IBBs Pharmaceutical Sector?
09:05AM  Moving Average Analysis of the Pharmaceutical Subgroup
Aug-11-15 04:01PM  Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference PR Newswire
04:01PM  Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference CNW Group
02:26PM  4 More Biotechs Leerink Is Looking At Post-Earnings
10:10AM  Company News for August 11, 2015 - Corporate Summary
Aug-10-15 06:24PM  Endo Q2 Earnings Beat Estimates, But Guidance On Hold at Investor's Business Daily
03:05PM  Stocks Maintain Big Gains; Hexcel Clears Buy Point at Investor's Business Daily
02:03PM  Edited Transcript of ENDP earnings conference call or presentation 10-Aug-15 12:00pm GMT
11:54AM  Endo reports 2Q loss
11:40AM  Endo Beats on Q2 Earnings and Revenues, Maintains View - Analyst Blog
08:43AM  Endo International Beats Revenue, Earnings Targets at The Wall Street Journal
08:00AM  Endo International plc Earnings Call scheduled for 8:00 am ET today
07:49AM  Endo (ENDP) Beats on Q2 Earnings, Guidance Reiterated - Tale of the Tape
07:47AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Results of Operations and Financial Condition
07:07AM  Q2 2015 Endo International PLC Earnings Release - Before Market Open
06:30AM  Endo Reports Second Quarter 2015 Financial Results PR Newswire
06:30AM  Endo Reports Second Quarter 2015 Financial Results CNW Group
Aug-07-15 05:10PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Financial Statements and Exhibits
02:25PM  Will Endo International's (ENDP) Q2 Earnings Disappoint? - Analyst Blog
Aug-05-15 07:00AM  Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals PR Newswire
07:00AM  Endo Divests Non-Core Business Lines from Litha Healthcare Group International Business, Enhancing Focus on Specialty Pharmaceuticals CNW Group
Aug-04-15 07:00AM  Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific PR Newswire
07:00AM  Endo Completes Divestiture of American Medical Systems' Men's and Prostate Health Businesses to Boston Scientific CNW Group
07:00AM  Boston Scientific Closes Acquisition Of The American Medical Systems Male Urology Portfolio PR Newswire
Jul-29-15 08:54AM  RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan
Jul-27-15 08:00AM  Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015 PR Newswire
08:00AM  Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015 CNW Group
Jul-23-15 02:57PM  Mylan's Stichting: Will It Work? at Barrons.com
02:04PM  Why Carl Icahn Warned about the High Yield Bond Market Bubble
11:11AM  Valeant Pharmaceuticals: All That Deal Making Pays Off? at Barrons.com
Jul-17-15 09:36AM  Up with Endo, Down with AllerganSort Of at Barrons.com
08:02AM  Painkiller Abuse Drives Drugmakers To Innovate at Investor's Business Daily
Jul-16-15 04:56PM  Heres Why This Hedge Fund Manager Sold Out Of Apple Inc (AAPL), Amazon.com Inc (AMZN), And Netflix Inc (NFLX) at Insider Monkey
03:59PM  Tenet Healthcare Headlined June in Junk Bond Issuance
Jul-14-15 01:06PM  Billionaire George Soros Latest Move Involves Cypress Semiconductor Corporation (CY); His Holdings Return -2.2% in Q2 at Insider Monkey
Jul-09-15 04:34PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial
Jul-02-15 01:06PM  Leveraged Loans Issuance Volume Picks Up in the Week of June 26
01:06PM  High Yield Bond Funds Witness Inflows in the Week of June 26
12:43PM  Billionaires George Soros and James Dinan Love These Stocks at Insider Monkey
Jul-01-15 03:46PM  Endo International: Biggest Junk Bond Issuer in Week of June 26
03:45PM  High Yield Bond Issuances Rise in the Week Ending June 26
01:13PM  Top Takeaways From BMO's Specialty Pharma Day
11:50AM  Egalet Reports Encouraging Results on Pain Drug Egalet-002 - Analyst Blog
12:38AM  Behind the Foreign Shopping Spree for U.S. Companies at The Wall Street Journal
Jun-30-15 06:57PM  Behind the Foreign Shopping Spree for U.S. Companies at The Wall Street Journal
Jun-25-15 04:07PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-24-15 04:30PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019 PR Newswire
04:01PM  Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019 CNW Group
01:19PM  Endo International plc Announces Pricing of Private Offering Of Senior Notes PR Newswire
01:19PM  Endo International plc Announces Pricing of Private Offering Of Senior Notes CNW Group
Jun-19-15 09:10AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Endo International plc Announces Proposed Private Offering Of Senior Notes PR Newswire
09:00AM  Endo International plc Announces Proposed Private Offering Of Senior Notes CNW Group
Jun-16-15 09:08AM  Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential at TheStreet
Jun-15-15 04:40PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib
Jun-11-15 12:20AM  Dodge & Cox Buys 2 New Stocks
Jun-10-15 06:32PM  Endo Finance LLC -- Moody's Confirms Endo's CFR at Ba3; outlook negative at Moody's
04:16PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Endo International plc Closes Offering of 27,627,628 Ordinary Shares PR Newswire
04:01PM  Endo International plc Closes Offering of 27,627,628 Ordinary Shares CNW Group
07:35AM  ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada Business Wire
Jun-09-15 04:48PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements
Jun-05-15 04:14PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:01AM  M&A boom: It's different this time Reuters
Jun-04-15 11:57PM  Endo International plc Prices Offering of 24,024,025 Ordinary Shares PR Newswire
11:57PM  Endo International plc Prices Offering of 24,024,025 Ordinary Shares CNW Group
Jun-03-15 11:22AM  The Morning Leverage: Synchronoss Exploring a Sale at The Wall Street Journal
Jun-02-15 06:27PM  Endo Plans Stock Sale to Fund Par Deal at The Wall Street Journal
05:35PM  Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares PR Newswire
05:35PM  Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares CNW Group
05:33PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events
11:13AM  Activist Keith Meisters New Additions to His Funds Portfolio Include Yum! Brands, Inc. (YUM), MGM Resorts International (MGM) at Insider Monkey
May-27-15 04:10PM  Tailwinds for US Equities Today
May-22-15 12:17PM  Will This Analyst Action Affect Endo Int'l. (ENDP) Stock? at TheStreet
May-21-15 06:05AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se
May-20-15 08:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
May-19-15 02:16PM  7 Biotech Stocks Moving Off The UBS Healthcare Conference
11:01AM  Pharma buying spree continues
10:10AM  Company News for May 19, 2015 - Corporate Summary
10:05AM  Fed afraid of everything: LaVorgna
09:34AM  Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon at TheStreet
09:30AM  DKS has a golf problem: Cramer
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain management, urology, CNS disorders, immunosuppression, oncology, women's health, hypertension, generic lidocaine patch, and other markets. The Devices segment provides various medical devices comprising AMS 800 artificial urinary sphincters, AMS 700 MS series, Monarc subfascial hammock products, Elevate anterior and posterior pelvic floor repair systems, and GreenLight XPS laser systems in the areas of men's and women's pelvic health. The International Pharmaceuticals segment offers Dexedrine, Tridural, Metadol, Trandate, Pennsaid, and Plan B products in therapeutic areas, including attention deficit hyperactivity disorder, pain, urology, and allergy. It sells its branded pharmaceuticals and generics directly to large pharmacy chains; and through wholesale drug distributors to pharmacies, hospitals, governmental agencies, and physicians. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.